enVVeno Medical (NVNO) Competitors $3.55 +0.24 (+7.25%) Closing price 04:00 PM EasternExtended Trading$3.56 +0.01 (+0.28%) As of 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVNO vs. LNSR, CVRX, ARAY, BWAY, CATX, SGHT, PROF, LUCD, OBIO, and INFUShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include LENSAR (LNSR), CVRx (CVRX), Accuray (ARAY), BrainsWay (BWAY), Perspective Therapeutics (CATX), Sight Sciences (SGHT), Profound Medical (PROF), Lucid Diagnostics (LUCD), Orchestra BioMed (OBIO), and InfuSystem (INFU). These companies are all part of the "surgical & medical instruments" industry. enVVeno Medical vs. LENSAR CVRx Accuray BrainsWay Perspective Therapeutics Sight Sciences Profound Medical Lucid Diagnostics Orchestra BioMed InfuSystem LENSAR (NASDAQ:LNSR) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership. Which has better earnings and valuation, LNSR or NVNO? LENSAR has higher revenue and earnings than enVVeno Medical. LENSAR is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLENSAR$53.49M3.08-$14.38M-$2.72-5.13enVVeno MedicalN/AN/A-$23.52M-$1.27-2.80 Does the MarketBeat Community prefer LNSR or NVNO? enVVeno Medical received 150 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 62.65% of users gave enVVeno Medical an outperform vote while only 37.50% of users gave LENSAR an outperform vote. CompanyUnderperformOutperformLENSAROutperform Votes637.50% Underperform Votes1062.50% enVVeno MedicalOutperform Votes15662.65% Underperform Votes9337.35% Do institutionals and insiders believe in LNSR or NVNO? 40.2% of LENSAR shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 66.0% of LENSAR shares are held by insiders. Comparatively, 16.0% of enVVeno Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, LNSR or NVNO? LENSAR has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500. Is LNSR or NVNO more profitable? enVVeno Medical has a net margin of 0.00% compared to LENSAR's net margin of -34.03%. enVVeno Medical's return on equity of -48.72% beat LENSAR's return on equity.Company Net Margins Return on Equity Return on Assets LENSAR-34.03% -49.02% -21.12% enVVeno Medical N/A -48.72%-45.96% Do analysts recommend LNSR or NVNO? LENSAR currently has a consensus target price of $15.00, indicating a potential upside of 7.45%. Given LENSAR's stronger consensus rating and higher probable upside, equities research analysts clearly believe LENSAR is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LENSAR 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00enVVeno Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to LNSR or NVNO? In the previous week, LENSAR had 5 more articles in the media than enVVeno Medical. MarketBeat recorded 7 mentions for LENSAR and 2 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.09 beat LENSAR's score of 1.01 indicating that enVVeno Medical is being referred to more favorably in the news media. Company Overall Sentiment LENSAR Positive enVVeno Medical Positive SummaryLENSAR and enVVeno Medical tied by winning 8 of the 16 factors compared between the two stocks. Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.25M$4.39B$5.55B$8.04BDividend YieldN/A39.93%5.09%4.22%P/E Ratio-2.7530.2822.7518.81Price / SalesN/A56.44403.93106.52Price / CashN/A51.0838.1834.62Price / Book1.026.226.794.33Net Income-$23.52M$68.15M$3.22B$247.85M7 Day Performance30.04%0.94%2.26%2.69%1 Month Performance37.07%-1.83%3.63%3.34%1 Year Performance-29.84%20.76%16.83%5.77% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno Medical1.206 of 5 stars$3.55+7.3%N/A-35.5%$62.25MN/A-2.7519Earnings ReportUpcoming EarningsNews CoveragePositive NewsGap UpHigh Trading VolumeLNSRLENSAR0.8939 of 5 stars$13.79-0.9%$15.00+8.8%+355.7%$162.57M$53.49M-9.45110Upcoming EarningsShort Interest ↑News CoveragePositive NewsCVRXCVRx3.1008 of 5 stars$6.06-3.0%$16.83+177.8%-28.0%$157.78M$51.29M-2.25160Upcoming EarningsShort Interest ↓News CoverageARAYAccuray2.8792 of 5 stars$1.45-2.0%N/A-37.8%$149.11M$453.14M-29.001,040Earnings ReportAnalyst RevisionNews CoverageGap UpBWAYBrainsWay3.1858 of 5 stars$7.86-4.6%$13.17+67.5%+58.5%$148.31M$41.02M78.61120Upcoming EarningsPositive NewsCATXPerspective Therapeutics3.6651 of 5 stars$1.92-1.0%$12.75+564.1%N/A$142.18M$1.43M0.0070Positive NewsSGHTSight Sciences2.992 of 5 stars$2.76+3.8%$3.83+38.9%-44.9%$141.68M$79.87M-2.71210Upcoming EarningsPROFProfound Medical2.263 of 5 stars$4.56-4.6%$14.25+212.5%-35.2%$136.98M$10.68M-3.40150Upcoming EarningsLUCDLucid Diagnostics2.4423 of 5 stars$1.20-0.8%$3.50+191.7%+46.8%$108.91M$4.35M-1.0570OBIOOrchestra BioMed2.8021 of 5 stars$2.84-0.4%$15.00+428.2%-37.5%$108.81M$2.64M-1.764News CoverageINFUInfuSystem1.4958 of 5 stars$4.91flat$13.00+164.8%N/A$103.19M$134.86M81.85410News Coverage Related Companies and Tools Related Companies LNSR Alternatives CVRX Alternatives ARAY Alternatives BWAY Alternatives CATX Alternatives SGHT Alternatives PROF Alternatives LUCD Alternatives OBIO Alternatives INFU Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVNO) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVNO Stock Free NVNO Stock Alerts